How many days does Lorlatinib/Lorlatinib (Borina) take to take effect?

Lorlatinib/The onset time of Lorlatinib (Lorlatinib) has always been a matter of widespread concern among patients. As a highly selective ALK/ROS1 targeted inhibitor, it controls tumor cell proliferation by deeply inhibiting abnormal signaling pathways. Its pharmacological mechanism determines that the drug's efficacy usually does not "act immediately" like antibiotics, but shows a gradual and stable improvement trend. Data show that lorlatinib reaches stable blood concentration in the body relatively quickly, and it generally reaches steady state within a few days to about a week after regular use, which usually means that the drug has begun to produce systemic effects.

Despite this, the speed of onset of action varies greatly depending on factors such as individual constitution, tumor biological characteristics, whether it is accompanied by brain metastasis, and previous types of resistance to targeted drugs. For non-small cell lung cancer patients with brain metastases, lorlatinib has excellent central penetrating ability, and its symptoms in the brain usually improve faster. Some patients can see relief of headaches or stabilization of neurological symptoms in the short term. However, at the imaging level, real "significant tumor shrinkage" often takes 4-8 weeks or even longer, which is a common evaluation period in large-scale clinical data. Therefore, if the patient does not experience significant improvement in symptoms in the first few weeks, it does not mean that the drug is ineffective, but it is a normal biological response time.

It should be emphasized that the evaluation of the efficacy of lorlatinib should be based on imaging review and doctor's judgment, rather than solely on personal feelings. Some patients may even experience temporary discomfort due to metabolic adjustments or mild adverse reactions in the early stages of taking the drug. However, as long as they insist on regular use and regular monitoring, it generally does not affect the overall efficacy of the drug. For patients who want to quickly judge the effect, doctors usually recommend an initial imaging evaluation a few weeks after starting treatment to comprehensively judge the drug response.

Reference materials：https://www.lorbrena.com/